Global medical charity Medecins Sans Frontieres slammed a statement by the chief executive of Bayer that the giant German firm only developed its cancer drug Nexavar for people who could afford the medicine, not "for Indians". India's controller general of patents angered Bayer in March 2012 when he authorised a local drugmaker to produce a generic copy of Nexavar, saying the German company charged a price that was too costly for most Indians. "We did ...
Read More
You have just read an article categorized health
titled Cancer Drug Nexavar too Costly for Most Indians.
Written by:
editor -
Saturday, January 25, 2014
There are currently no comments for "Cancer Drug Nexavar too Costly for Most Indians"
Post a Comment